Research progress of Phyllanthi Fructus and prediction of its Q-markers / 中国中药杂志
China Journal of Chinese Materia Medica
; (24): 5533-5544, 2021.
Article
de Zh
| WPRIM
| ID: wpr-921735
Bibliothèque responsable:
WPRO
ABSTRACT
Phyllanthi Fructus, a unique Chinese and Tibetan medicinal plant with both edible and medical values, has high potential of cultivation and development. The resources of Phyllanthi Fructus in China are rich, mainly distributed in Yunnan, Sichuan, Fujian, Guangdong, Guangxi, etc. Phyllanthi Fructus is widely used in the clinical practice of Chinese medicine and plays an important role in Tibetan medicine, Uyghur medicine, Yi medicine, and Mongolian medicine. Phyllanthi Fructus mainly contains phenolic acids,tannins, terpenes, sterols, fatty acids, flavonoids, amino acids and other compounds. Modern pharmacological studies show that Phyllanthi Fructus has antioxidant, anticancer, blood lipid-lowering, liver protective, antimicrobial, anti-inflammatory, and immune regulatory activities. In this paper, the research status of Phyllanthi Fructus was reviewed from the aspects of herbal textual research,chemical composition, and pharmacological action. The quality markers(Q-markers) of Phyllanthi Fructus were predicted and analyzed from the aspects of biogenic pathway, specificity and measurability of chemical components, efficacy, properties, new clinical uses, drug-food homology, and transformation of polyphenols. The results will provide a scientific basis for the quality control, quality evaluation, and standard formulation of Phyllanthi Fructus.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Contrôle de qualité
/
Médicaments issus de plantes chinoises
/
Chine
/
Médecine traditionnelle tibétaine
/
Fruit
Type d'étude:
Prognostic_studies
Pays comme sujet:
Asia
langue:
Zh
Texte intégral:
China Journal of Chinese Materia Medica
Année:
2021
Type:
Article